Immune-Checkpoint Inhibitors Combinations in Metastatic NSCLC: New Options on the Horizon?

Overview of attention for article published in ImmunoTargets and Therapy, February 2021

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 16 Dimensions

Readers on

mendeley: 26 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 1,093 followers.

Immune-Checkpoint Inhibitors Combinations in Metastatic NSCLC: New Options on the Horizon? https://t.co/gaZGLKo3jm

Reply Repost Favourite

Immune-Checkpoint Inhibitors Combinations in Metastatic NSCLC: New Options on the Horizon? #NSCLC #immunotherapy @DovePress https://t.co/tuaaPEcln6

Reply Repost Favourite